Nykode Therapeutics AS (FRA:5VB)
Germany
· Delayed Price · Currency is EUR 0.1571
-0.0047 (-2.90%)
At close: Dec 5, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of €67.67 million as of December 5, 2025. Its market cap has decreased by -12.26% in one year.
Market Cap
67.67M
Enterprise Value
15.86M
Revenue
6.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.16
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 549.42M to 67.67M, a decrease of -87.68%. That is a compound annual growth rate of -30.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 67.67M | -19.72% |
| Dec 30, 2024 | 84.29M | -86.48% |
| Dec 29, 2023 | 623.47M | -20.78% |
| Dec 30, 2022 | 787.04M | -66.41% |
| Dec 30, 2021 | 2.34B | 15.26% |
| Dec 30, 2020 | 2.03B | 270.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |